Latest Articles
March 25, 2026
The CARE Difference: A Smarter Workflow for High‑Risk Screening
Danielle Rogers, oncology and genetics nurse practitioner, recently shared her experience with providing personalized assessments of cancer risks before and after implementation of the Ambry…
BRCA1 & 2
Breast Cancer
March 24, 2026
The Gene Scene: SMAD4
Rachel Bluebond explores SMAD4 and its associated conditions of juvenile polyposis syndrome (JPS) and Myhre syndrome.
Gene Scene
Genetic Counselors
Genetic Testing
March 17, 2026
The Gene Scene: CASQ2
The Gene Scene covers CASQ2 from the ACMG Secondary Findings list and it’s link to CASQ2-related catecholaminergic polymorphic ventricular tachycardia (CPVT).
Cardio
Genetic Testing
March 11, 2026
Making Waves with MAVES
Discover how a BRCA2 variant reclassification, thanks in part to new MAVEs data and the Ambry Classifi® Program, unlocked potentially life-saving options for a 2x…
BRCA
Breast Cancer
Genetic Testing
Genetic Testing Accuracy
MAVES
March 10, 2026
The Gene Scene: CALM2
In this Gene Scene, Katherine Crawford covers gene-disase validity in the CALM2 gene leading CALM2–related calmodulinopathy with clinical considerations for genetic counselors.
Cardio
Gene Scene
Genetic Counselors
Genetic Testing
March 4, 2026
Where Genomic Insights Meet Clinical Action
Seth Berger discusses wins in genome and exome genetic testing and clinical insights for future advancements.
Genomics
Whole Exome Sequencing
whole genome sequencing